ID
24050
Beskrivning
Study ID: 100716 Clinical Study ID: NKP100716 Study Title: An open label repeat dose study to investigate the effect of GW597599 (15 mg) and paroxetine (10 mg) given in combination for 15 days on the pharmacokinetics of midazolam and dextromethorphan in healthy male and female volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: vestipitant Trade Name: paroxetine and vestipitant Study Indication: Depressive Disorder and Anxiety Disorders Documentation part: Pharmacogenetic Research, Prior And Concomitant Medication, Baseline Signs and Symptoms
Nyckelord
Versioner (2)
- 2017-07-24 2017-07-24 -
- 2021-09-20 2021-09-20 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
24 juli 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
GW597599 and paroxetine on the pharmacokinetics of midazolam and dextromethorphan 100716 Pharmacogenetic Research, Prior And Concomitant Medication, Baseline Signs And Symptoms
GW597599 and paroxetine on the pharmacokinetics of midazolam and dextromethorphan 100716 Pharmacogenetic Research, Prior And Concomitant Medication, Baseline Signs And Symptoms
Beskrivning
Prior Medication
Alias
- UMLS CUI-1
- C0013227
Beskrivning
If Yes, please record the medications below.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0013227
Beskrivning
drug name
Datatyp
text
Alias
- UMLS CUI [1]
- C0013227
Beskrivning
dosage
Datatyp
text
Alias
- UMLS CUI [1]
- C0178602
Beskrivning
frequency of this dose
Datatyp
text
Alias
- UMLS CUI [1]
- C3476109
Beskrivning
administration route
Datatyp
text
Alias
- UMLS CUI [1]
- C0013153
Beskrivning
medication indication
Datatyp
text
Alias
- UMLS CUI [1]
- C3146298
Beskrivning
duration of therapy
Datatyp
text
Alias
- UMLS CUI [1]
- C0444917
Beskrivning
medication end date
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C0013227
Beskrivning
continuing medication at end of study
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1553904
Beskrivning
Baseline Signs Ans Symptoms
Alias
- UMLS CUI-1
- C0037088
- UMLS CUI-2
- C1442488
Beskrivning
diagnosis
Datatyp
text
Alias
- UMLS CUI [1]
- C0011900
Beskrivning
onset date and time
Datatyp
datetime
Alias
- UMLS CUI [1,1]
- C2981441
- UMLS CUI [1,2]
- C1442488
Beskrivning
end date and time
Datatyp
datetime
Alias
- UMLS CUI [1,1]
- C2981425
- UMLS CUI [1,2]
- C1442488
Beskrivning
outcome
Datatyp
text
Alias
- UMLS CUI [1]
- C1705586
Beskrivning
event course
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0750729
Beskrivning
intensity
Datatyp
text
Alias
- UMLS CUI [1]
- C0518690
Beskrivning
relationship to study procedures
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1510821
Beskrivning
If Yes, please record on Prior Medication form.
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0559546
- UMLS CUI [1,2]
- C0087111
Beskrivning
subject withdrawn due to event
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0877248
Similar models
GW597599 and paroxetine on the pharmacokinetics of midazolam and dextromethorphan 100716 Pharmacogenetic Research, Prior And Concomitant Medication, Baseline Signs And Symptoms
C0021430 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0178913 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0013227 (UMLS CUI [1,2])
C1442488 (UMLS CUI-2)
C1442488 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,2])
C1510821 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])